NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NEI E-304-2003-0-CA-03 Venting and Drying of Samples in Multi-Well Plates CA National Stage 2497965 Abandoned
NCI E-082-2004-2-JP-05 Methods of Preventing or Treating T Cell Malignancies by Adminstering CD2 Antagonists JP National Stage 2004-534750 Abandoned
NHLBI E-223-2002-0-US-03 FACTORS THAT BIND INTESTNAL TOXINS US National Stage 10/526,820 Abandoned
NCI E-245-2002-0-JP-06 AKT INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF JP National Stage 2004-534522 Abandoned
NIAMS E-014-2005-0-US-01 Novel Bioreactor System For Fabrication Of Tissue Engineering Constructs And Culture Under Applied, Controlled Dynamic Mechanical Stimulation US 60/658,286 Abandoned
NCI E-082-2005-1-US-01 SIPA-1 GENE AND SIPA-1 INHIBITOR FOR THE TREATMENT, PREVENTION, AND DIAGNOSIS OF CANCER US 60/657,943 Abandoned
NICHD E-155-1999-0-US-07 Structural Modification of 19-Norprogesterone I: 17-Alpha-Substituted-11-Beta-4-Substituted-Aryl and 21-Substituted 19-Norpregnadienedione as New Antiprogestational Agents US DIV 11/069,817 8569276 Expired PDF
CC E-238-2003-0-PCT-02 Detection and Identification of Mycobacterium and Noncardia Using SECA PCT PCT PCT/US2005/06609 Expired
NCI E-069-2005-0-US-01 Mammary Gland Differentiation By 2-Methoxyestradiol US 60/657,301 Abandoned
NIAID E-323-2005-1-US-01 Vaccines Against Potential Pandemic Strains Of Influenza US 60/657,554 Abandoned
NCI E-094-2004-0-CA-05 Pharmacodynamic Assays Using Flow Cytometry CA National Stage 2557568 Abandoned
NCI E-094-2004-0-AU-04 Pharmacodynamic Assays Using Flow Cytometry AU National Stage 2005218769 Abandoned
NCI E-094-2004-0-DE-07 Pharmacodynamic Assays Using Flow Cytometry DE EP 05723905.5 Abandoned
NCI E-094-2004-0-FR-08 Pharmacodynamic Assays Using Flow Cytometry FR EP 05723905.5 Abandoned
NCI E-094-2004-0-GB-09 Pharmacodynamic Assays Using Flow Cytometry GB EP 05723905.5 Abandoned
NCI E-094-2004-0-EP-03 Pharmacodynamic Assays EP National Stage 05723905.5 Abandoned
NCI E-094-2004-0-PCT-02 Pharmacodynamic Assays PCT PCT PCT/US2005/006236 Expired
NIDDK E-056-2004-0-PCT-02 STAMP MODULATION OF GLUCOCORTICOID-RESPONSIVE GENE EXPRESSION PCT PCT PCT/US2005/006393 Abandoned
NCI E-074-2004-0-PCT-02 Methylation Inhibitor Compounds PCT PCT PCT/US2005/006173 Expired
NCI E-079-2004-0-US-01 BIOLOGICAL MATERIALS AND USES THEREOF US ORD 11/066,045 Abandoned
NIDDK E-056-2004-0-EP-06 A Novel Modulator of Glucocorticoid Receptor Activities EP National Stage 05724026.9 Abandoned
NCI E-074-2004-0-EP-05 Methylation Inhibitor Compounds EP National Stage 05723859.4 Abandoned
NIDDK E-056-2004-0-US-07 Novel CoFactor Modulates Steroid Receptor Activities US DIV 12/899,356 Abandoned
NIDDK E-078-2007-0-US-01 Bicyclo (3.1.0) Hexane Derivatives As Antiviral Compounds US 60/656,689 Abandoned
NIDDK E-056-2004-0-CA-05 A NOVEL COFACTOR THAT MODULATES STEROID RECEPTOR ACTIVITIES CA National Stage 2557597 Abandoned
NCI E-074-2004-0-CA-04 Methylation Inhibitor Compounds CA National Stage 2557075 Abandoned
NCI E-074-2004-0-AU-06 Methylation Inhibitor Compounds AU National Stage 2005216971 Abandoned
NIDDK E-056-2004-0-AU-04 STAMP MODULATION OF GLUCOCORTICOID-RESPONSIVE GENE EXPRESSION AU National Stage 2005217646 Abandoned
NIA E-203-2006-2-US-01 LOI Of Igf2 Increases Intestional Stem Cell Compartment And Adenoma Formation US 60/656,470 Abandoned
NICHD E-016-1996-0-US-25 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS US DIV 11/065,632 7087591 Expired PDF
NCI E-128-2004-2-PCT-01 Cytonectin Gene And Related Antibodies In Tauopathy, Cancer And Arthritis PCT PCT COMB PCT/US2005/05793 Abandoned
NCI E-069-2004-0-PCT-02 Formylpeptide Receptor (FPR) as a Target for Anti-Malignant Glioma Therapy PCT PCT PCT/US2005/05652 Expired
NCI E-110-2004-0-PCT-02 New Anti-Tumor Phosphatase Inhibitors PCT PCT PCT/US2005/05742 Expired
CC E-001-2001-1-US-02 Apheresis Methods and Devices US CON 11/067,405 Abandoned
NCI E-207-2004-2-US-01 Generation Of Plasmids With The Prophage Lamba Immunity Region, PL Promoter, And Red Genes For Transfer To Other Gram Negative Bacteria For The Purpose Of Recombineering In Those Organisms US 60/655,729 Abandoned
NCI E-079-2005-0-US-01 Methods and Compositions for Treating Cervical Cancer US 60/655,315 Abandoned
NCI E-137-2003-1-US-01 Vaccines and Methods for Prevent and Treatment of Drug Resistance HIV-1 and Hepatitis B Virus US 60/655,984 Abandoned
NCI E-110-2004-0-AU-03 New Anti-Tumor Phosphatase Inhibitors AU National Stage 2005216200 Abandoned
NCI E-110-2004-0-CA-04 Maleiimide Anti-Tumor Phosphate Inhibitors CA National Stage 2555711 Abandoned
NCI E-041-2005-0-US-01 Diagnostic FISH Marker To Identify Cervical Pap Smears Revealing Disease Progression Potential US 60/654,176 Abandoned
NCI E-086-1999-0-US-07 Nucleic Acid and Amino Acid Sequences of Hemoglobin-Response Genes in Candida Albicans and the Use of RReagents Derived From These Sequences in the Diagnosis of Disseminated Candida Albicans Infection US DIV 11/060,295 7332167 Abandoned PDF
NCI E-325-2002-0-PCT-02 ANTIBODIES THAT BIND POTE AND USES THEREOF PCT PCT PCT/US2005/005419 Abandoned
NIAID E-022-2008-0-US-01 MOLECULAR SCAFFOLDS FOR HIV-1 IMMUNOGENS US 60/654,340 Abandoned
NHGRI E-068-2005-0-US-01 Identification Of Molecular Diagnostic Markers For Endometriosis In Blood Lymphocytes US 60/654,331 Abandoned
NIAID E-123-2005-0-US-01 The HIV Gp-41-Membrane Proximal Region Arrayed on Hepatitis B Surface Antigen Particles as Novel Antigens US 60/653,930 Abandoned
NIMH E-281-2005-0-US-01 Quantum-dot/bacteriophage (PhageQdot) To Detect Biological Target In Clinical Or Enviromental Isolates US 60/654,784 Abandoned
NCI E-019-2005-0-US-01 Synergistic Effect Of TGF-beta Blockade and Immunogenic Agents on Tumors US 60/654,329 Abandoned
NIAID E-233-2003-2-US-01 Inhibition Of HIV-1 Replication By Disruption Of The Processing Of The Viral Capsid-Spacer Peptide 1 Protein US 60/653,961 Abandoned
NCI E-191-2002-0-GB-13 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF GB EP 03751813.1 Expired
NCI E-191-2002-0-FR-12 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF FR EP 03751813.1 Expired